Table 5.
Volume N = 110 | HPV+ | HPV- | Total |
p-value Risk analysis |
---|---|---|---|---|
6 Months | ||||
> = 36.5 | 32 | 23 | 55 | p < 0.001 |
<36.5 | 13 | 42 | 55 | RR = 2.46 95 %ϵ(1.45; 4.16) |
Total | 45 | 65 | 110 | |
12 Months | ||||
> = 36.5 | 16 | 39 | 55 | p = 0.0171 |
<36.5 | 6 | 49 | 55 | RR = 2.67 95 %ϵ(1.13; 6.30) |
Total | 22 | 88 | 110 | |
18 Months | ||||
> = 36.5 | 8 | 47 | 55 | p = 0.3755 |
<36.5 | 5 | 50 | 55 | RR = 1.60 95 %ϵ(0.55; 4.58) |
Total | 13 | 97 | 110 |
Risk analysis for the persistence of HPV coinfections (the contingence tables, the p values, the relative risk values and the risk inference intervals for 95 % of the population). We marked with co-infections (HPV+) the patients who have at least two different HPV types and with HPV- patients who have just one HPV type. We considered as an exposure the age above 36.5 years